The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the ...
Read More
The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups--the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)--all of which were or still are centers of worldwide, heated controversy.
Read Less
Add this copy of Bad Medicine: the Prescription Drug Industry in the to cart. $7.94, good condition, Sold by ThriftBooks-Reno rated 5.0 out of 5 stars, ships from Reno, NV, UNITED STATES, published 1992 by Stanford University Press.
Add this copy of Bad Medicine: the Prescription Drug Industry in the to cart. $9.29, very good condition, Sold by Bingo Used Books rated 5.0 out of 5 stars, ships from Vancouver, WA, UNITED STATES, published 1992 by Stanford University Press.
Add this copy of Bad Medicine to cart. $34.95, good condition, Sold by J.E. Miles, A Bookseller rated 5.0 out of 5 stars, ships from OCEANSIDE, CA, UNITED STATES, published 1992 by Stanford University.
Add this copy of Bad Medicine: the Prescription Drug Industry in the to cart. $38.39, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 1992 by Stanford University Press.
Add this copy of Bad Medicine: the Prescription Drug Industry in the to cart. $43.29, fair condition, Sold by BookHolders rated 5.0 out of 5 stars, ships from Gambrills, MD, UNITED STATES, published 1992 by Stanford University Press.
Add this copy of Bad Medicine: the Prescription Drug Industry in the to cart. $57.50, very good condition, Sold by Bingo Used Books rated 5.0 out of 5 stars, ships from Vancouver, WA, UNITED STATES, published 1992 by Chicago, Illinois, U.S.A. : Stanford Univ Pr.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Near Fine in Very Good jacket. Hardback in near fine condition with very good minus dust jacket. Few spots on top edge. Wrinkle/crease on front of dust jacket.
Add this copy of Bad Medicine: The Prescription Drug Industry in the to cart. $75.49, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 1992 by Stanford University Press.
Add this copy of Bad Medicine: the Prescription Drug Industry in the to cart. $79.95, new condition, Sold by GridFreed rated 5.0 out of 5 stars, ships from North Las Vegas, NV, UNITED STATES, published 1992 by Stanford University Press.
Add this copy of Bad Medicine: The Prescription Drug Industry in the to cart. $82.52, new condition, Sold by GreatBookPrices rated 4.0 out of 5 stars, ships from Columbia, MD, UNITED STATES, published 1992 by Stanford University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Sewn binding. Cloth over boards. 380 p. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.